{"count": 47, "results": [{"_id": "35873646", "pmid": 35873646, "pmcid": "PMC9303163", "title": "Simvastatin in the Treatment of Colorectal Cancer: A Review", "journal": "Evid Based Complement Alternat Med", "authors": ["Zang H", "Yang W", "Tian X"], "date": "2022-07-14T00:00:00Z", "doi": "10.1155/2022/3827933", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "3827933", "score": 50286.19, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in the Treatment of @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@Colorectal Cancer@@@: A Review", "citations": {"NLM": "Zang H, Yang W, Tian X. Simvastatin in the Treatment of Colorectal Cancer: A Review Evid Based Complement Alternat Med. 2022;2022():3827933. PMID: 35873646", "BibTeX": "@article{35873646, title={Simvastatin in the Treatment of Colorectal Cancer: A Review}, author={Zang H and Yang W and Tian X}, journal={Evid Based Complement Alternat Med}, volume={2022}, pages={3827933}}"}}, {"_id": "37974278", "pmid": 37974278, "pmcid": "PMC10652480", "title": "Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer", "journal": "Cell Commun Signal", "authors": ["Xie W", "Peng M", "Liu Y", "Zhang B", "Yi L", "Long Y"], "date": "2023-11-16T00:00:00Z", "doi": "10.1186/s12964-023-01359-y", "meta_date_publication": "2023 Nov 16", "meta_volume": "21", "meta_issue": "1", "meta_pages": "329", "score": 50281.84, "text_hl": "To further decipher the effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@colon cancer@@@ cells, we investigated if @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ induced pyroptosis in @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@colon cancer@@@ cells. ", "citations": {"NLM": "Xie W, Peng M, Liu Y, Zhang B, Yi L, Long Y. Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer Cell Commun Signal. 2023 Nov 16;21(1):329. PMID: 37974278", "BibTeX": "@article{37974278, title={Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer}, author={Xie W and Peng M and Liu Y and Zhang B and Yi L and Long Y}, journal={Cell Commun Signal}, volume={21}, number={1}, pages={329}}"}}, {"_id": "38093875", "pmid": 38093875, "pmcid": "PMC10718690", "title": "Retracted: Simvastatin in the Treatment of Colorectal Cancer: A Review", "journal": "Evid Based Complement Alternat Med", "authors": ["And Alternative Medicine EC"], "date": "2023-12-06T00:00:00Z", "doi": "10.1155/2023/9767203", "meta_date_publication": "2023", "meta_volume": "2023", "meta_issue": "", "meta_pages": "9767203", "score": 50271.633, "text_hl": "Retracted: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in the Treatment of @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@Colorectal Cancer@@@: A Review", "citations": {"NLM": "And Alternative Medicine EC. Retracted: Simvastatin in the Treatment of Colorectal Cancer: A Review Evid Based Complement Alternat Med. 2023;2023():9767203. PMID: 38093875", "BibTeX": "@article{38093875, title={Retracted: Simvastatin in the Treatment of Colorectal Cancer: A Review}, author={And Alternative Medicine EC}, journal={Evid Based Complement Alternat Med}, volume={2023}, pages={9767203}}"}}, {"_id": "34557254", "pmid": 34557254, "pmcid": "PMC8455186", "title": "Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer", "journal": "Evid Based Complement Alternat Med", "authors": ["Li G", "Liu J"], "date": "2021-09-13T00:00:00Z", "doi": "10.1155/2021/2280440", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "2280440", "score": 50264.527, "text_hl": "Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with @CHEMICAL_Cetuximab @CHEMICAL_MESH:D000068818 @@@Cetuximab@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in the Treatment of @GENE_KRAS @GENE_3845 @@@K-RAS@@@ Mutant @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@Colorectal Cancer@@@", "citations": {"NLM": "Li G, Liu J. Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer Evid Based Complement Alternat Med. 2021;2021():2280440. PMID: 34557254", "BibTeX": "@article{34557254, title={Analysis of Efficacy, Safety, and Prognostic Factors of mFOLFOX6 Regimen Combined with Cetuximab and Simvastatin in the Treatment of K-RAS Mutant Colorectal Cancer}, author={Li G and Liu J}, journal={Evid Based Complement Alternat Med}, volume={2021}, pages={2280440}}"}}, {"_id": "32344610", "pmid": 32344610, "pmcid": "PMC7231066", "title": "Chitosan Coated Microparticles Enhance Simvastatin Colon Targeting and Pro-Apoptotic Activity", "journal": "Mar Drugs", "authors": ["Alhakamy NA", "Fahmy UA", "Ahmed OAA", "Caruso G", "Caraci F", "Asfour HZ", "Bakhrebah MA", "N Alomary M", "Abdulaal WH", "Okbazghi SZ", "Abdel-Naim AB", "Eid BG", "Aldawsari HM", "Kurakula M", "Mohamed AI"], "date": "2020-04-24T00:00:00Z", "doi": "10.3390/md18040226", "meta_date_publication": "2020 Apr 24", "meta_volume": "18", "meta_issue": "4", "meta_pages": "", "score": 50264.434, "text_hl": "This work aimed at improving the targeting and @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@cytotoxicity@@@ of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SMV@@@) against @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@colon cancer@@@ cells. ", "citations": {"NLM": "Alhakamy NA, Fahmy UA, Ahmed OAA, Caruso G, Caraci F, Asfour HZ, Bakhrebah MA, N Alomary M, Abdulaal WH, Okbazghi SZ, Abdel-Naim AB, Eid BG, Aldawsari HM, Kurakula M, Mohamed AI. Chitosan Coated Microparticles Enhance Simvastatin Colon Targeting and Pro-Apoptotic Activity Mar Drugs. 2020 Apr 24;18(4):. PMID: 32344610", "BibTeX": "@article{32344610, title={Chitosan Coated Microparticles Enhance Simvastatin Colon Targeting and Pro-Apoptotic Activity}, author={Alhakamy NA and Fahmy UA and Ahmed OAA and Caruso G and Caraci F and Asfour HZ and Bakhrebah MA and N Alomary M and Abdulaal WH and Okbazghi SZ and Abdel-Naim AB and Eid BG and Aldawsari HM and Kurakula M and Mohamed AI}, journal={Mar Drugs}, volume={18}, number={4}}"}}, {"_id": "40487942", "pmid": 40487942, "title": "Simvastatin inhibits proliferation and migration, promotes oxidative stress and ferroptosis in colon cancer.", "journal": "World J Gastrointest Oncol", "authors": ["Liu Y", "Ge H", "Fan ZM", "Lu T", "He L", "Li M", "Zhao HR", "Leng Q"], "date": "2025-05-15T00:00:00Z", "doi": "10.4251/wjgo.v17.i5.104522", "meta_date_publication": "2025 May 15", "meta_volume": "17", "meta_issue": "5", "meta_pages": "104522", "score": 50262.87, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ inhibits proliferation and migration, promotes oxidative stress and ferroptosis in @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@colon cancer@@@.", "citations": {"NLM": "Liu Y, Ge H, Fan ZM, Lu T, He L, Li M, Zhao HR, Leng Q. Simvastatin inhibits proliferation and migration, promotes oxidative stress and ferroptosis in colon cancer. World J Gastrointest Oncol. 2025 May 15;17(5):104522. PMID: 40487942", "BibTeX": "@article{40487942, title={Simvastatin inhibits proliferation and migration, promotes oxidative stress and ferroptosis in colon cancer.}, author={Liu Y and Ge H and Fan ZM and Lu T and He L and Li M and Zhao HR and Leng Q}, journal={World J Gastrointest Oncol}, volume={17}, number={5}, pages={104522}}"}}, {"_id": "36703094", "pmid": 36703094, "title": "Repositioning of simvastatin for diabetic colon cancer: role of CDK4 inhibition and apoptosis.", "journal": "Mol Cell Biochem", "authors": ["Gajjar S", "Bora V", "Patel BM"], "date": "2023-01-27T00:00:00Z", "doi": "10.1007/s11010-023-04663-w", "meta_date_publication": "2023 Jan 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50261.09, "text_hl": "Repositioning of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@diabetic colon cancer@@@: role of @GENE_CDK4 @GENE_1019 @@@CDK4@@@ inhibition and apoptosis.", "citations": {"NLM": "Gajjar S, Bora V, Patel BM. Repositioning of simvastatin for diabetic colon cancer: role of CDK4 inhibition and apoptosis. Mol Cell Biochem. 2023 Jan 27;():. PMID: 36703094", "BibTeX": "@article{36703094, title={Repositioning of simvastatin for diabetic colon cancer: role of CDK4 inhibition and apoptosis.}, author={Gajjar S and Bora V and Patel BM}, journal={Mol Cell Biochem}}"}}, {"_id": "34683821", "pmid": 34683821, "pmcid": "PMC8537800", "title": "A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy", "journal": "Pharmaceutics", "authors": ["Barbălată CI", "Porfire AS", "Sesarman A", "Rauca VF", "Banciu M", "Muntean D", "Știufiuc R", "Moldovan A", "Moldovan C", "Tomuță I"], "date": "2021-09-22T00:00:00Z", "doi": "10.3390/pharmaceutics13101526", "meta_date_publication": "2021 Sep 22", "meta_volume": "13", "meta_issue": "10", "meta_pages": "", "score": 50257.453, "text_hl": "A Screening Study for the Development of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@-@CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@Doxorubicin@@@ Liposomes, a Co-Formulation with Future Perspectives in @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@Colon Cancer@@@ Therapy", "citations": {"NLM": "Barbălată CI, Porfire AS, Sesarman A, Rauca VF, Banciu M, Muntean D, Știufiuc R, Moldovan A, Moldovan C, Tomuță I. A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy Pharmaceutics. 2021 Sep 22;13(10):. PMID: 34683821", "BibTeX": "@article{34683821, title={A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy}, author={Barbălată CI and Porfire AS and Sesarman A and Rauca VF and Banciu M and Muntean D and Știufiuc R and Moldovan A and Moldovan C and Tomuță I}, journal={Pharmaceutics}, volume={13}, number={10}}"}}, {"_id": "33430677", "pmid": 33430677, "title": "Simvastatin nanosuspensions prepared using a combination of pH-sensitive and timed-release approaches for potential treatment of colorectal cancer.", "journal": "Pharm Dev Technol", "authors": ["Taymouri S", "Ahmadi Z", "Mirian M", "Tavakoli N"], "date": "2021-03-01T00:00:00Z", "doi": "10.1080/10837450.2021.1872086", "meta_date_publication": "2021 Mar", "meta_volume": "26", "meta_issue": "3", "meta_pages": "335-348", "score": 50257.414, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ nanosuspensions prepared using a combination of pH-sensitive and timed-release approaches for potential treatment of @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@colorectal cancer@@@.", "citations": {"NLM": "Taymouri S, Ahmadi Z, Mirian M, Tavakoli N. Simvastatin nanosuspensions prepared using a combination of pH-sensitive and timed-release approaches for potential treatment of colorectal cancer. Pharm Dev Technol. 2021 Mar;26(3):335-348. PMID: 33430677", "BibTeX": "@article{33430677, title={Simvastatin nanosuspensions prepared using a combination of pH-sensitive and timed-release approaches for potential treatment of colorectal cancer.}, author={Taymouri S and Ahmadi Z and Mirian M and Tavakoli N}, journal={Pharm Dev Technol}, volume={26}, number={3}, pages={335-348}}"}}, {"_id": "37069612", "pmid": 37069612, "pmcid": "PMC10108455", "title": "Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy", "journal": "Cancer Cell Int", "authors": ["Tsubaki M", "Takeda T", "Matsuda T", "Kishimoto K", "Takefuji H", "Taniwaki Y", "Ueda M", "Hoshida T", "Tanabe K", "Nishida S"], "date": "2023-04-17T00:00:00Z", "doi": "10.1186/s12935-023-02884-z", "meta_date_publication": "2023 Apr 17", "meta_volume": "23", "meta_issue": "1", "meta_pages": "73", "score": 50253.113, "text_hl": "Effect of @CHEMICAL_Oxaliplatin @CHEMICAL_MESH:D000077150 @@@L-OHP@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, and @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@fluvastatin@@@ on @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@colorectal cancer@@@ cell survival and statins enhanced the sensitivity to @CHEMICAL_Oxaliplatin @CHEMICAL_MESH:D000077150 @@@L-OHP@@@ in @GENE_KRAS @GENE_3845 @@@KRAS@@@-mutated @<m>DISEASE_Colorectal_Neoplasms</m> @DISEASE_MESH:D015179 @@@colorectal cancer@@@ cells", "citations": {"NLM": "Tsubaki M, Takeda T, Matsuda T, Kishimoto K, Takefuji H, Taniwaki Y, Ueda M, Hoshida T, Tanabe K, Nishida S. Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy Cancer Cell Int. 2023 Apr 17;23(1):73. PMID: 37069612", "BibTeX": "@article{37069612, title={Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy}, author={Tsubaki M and Takeda T and Matsuda T and Kishimoto K and Takefuji H and Taniwaki Y and Ueda M and Hoshida T and Tanabe K and Nishida S}, journal={Cancer Cell Int}, volume={23}, number={1}, pages={73}}"}}]}